A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

An obesity medicine physician writes that weight-loss drugs such as Ozempic have been getting a bad rap, almost as if those ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

You've probably seen the headlines about Rebel Wilson's incredible weight loss transformation. The actress, known for ...

Plastic surgeons say business is booming as users of obesity drugs reassess how they look.

Dr. Sue Mitchell is an experienced gastroenterologist with a background in functional medicine, internal medicine and ...

There have been numerous reports on social media platforms like TikTok and Instagram where women have shared experiences of ...

As the ‘miracle’ drugs sweep the globe, pubs, bars and drinks manufacturers are scrambling to cope with an unexpected side ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...